Phenylephrine ointment
These results indicated that the leftward shift in the concentration– response curve for phenylephrine in the reserpine-treated artery were caused by a bmy 7378-sensitive but kmd-3213-insensitive component, which was not detected in the reserpine-untreated arterial tissues.
TABLE 2. Changes in Electrophysiological Data of Retrograde Fast Pathway During Phenylephrine Infusion in Patients With AVNRT.
Frsistent Tardive Dyskinesia: As with alt antipsychotic agents tardive dyskinesia may appear in some patients on tong term therapy or may occur after drug therapy has been discontinued. The risk seems to be greater in elderly patients on high-dose therapy, especialfy females The symptoms are persistent and in some patients appear to be irreversible. The syndrome is characterized by rhythmical involuntary movements ofthe tongue, face, mouth or law e g , protrusion of tongue, puffing of cheeks. puckering of mouth, chewing movements ; . Sometimes these may be accompanied by involuntary movements of extremities. There is no known effective treatment for tardive dyskinesia, antiparkinsonism agents usually do not alleviate the symptoms ofthis syndrome It is suggested that all antipsychotic agents be discontinued if these symptoms appear Should it be necessary to reinstitute treatment, or increase the dosage ofthe agent, or switch to a different antipsychotic agent. the syndrome may be masked It has been reported that fine vermicular movements of the tongue may be an early sign of the syndrome and if the medication is stopped at that time, the syndrome may not develop Hepatic effects Elevations of serum transaminase and alkaline phosphatase, usually ransient, have been infrequently observed in some patients No clinically confirmed cases of jaundice attributable to Navane have been reported Hematologic effects As is true with certain other psychotropic drugs, leukopenia and leukocytosis, which are usually transient. can occur occasionally with Navane Other antipsychotic drugs have been associated with agranulocytosis. eosinophilia, hemolytic anemia, thrombocytopenia and pancytopenia Allergic reactions Rash. pruritus, urticaria. photosensitivity and rare cases of anaphylaxis have been reported with Navane Undue exposure to sunlight should be avoided. Although not experienced with Navane, exfoliative dermatitis and contact dermatitis ; in nursing personnel ; have been reported with certain phenothiazines Endocrine disorders Lactation, moderate breast enlargement and amenorrhea have occurred in a small percentage of females receiving Navane. If persistent, this may necessitate a reduction in dosage or the discontinuation of therapy Phenothiazines have been associated with false positive pregnancy tests, gynecomastia. hypoglycemia, hyperglycemia, and glycosuria Autonomic effects Dry mouth, blurred vision, nasal congestion, constipation, increased sweating, increased salivation. and impotence have occurred infrequently with Navane therapy. Phenothiazines have been associated with miosis, mydriasis, and adynamic ileus Other adverse reactions: Hyperpyrexia, anorexia, nausea. vomiting. diarrhea, increase in appetite and weight. weakness or fatigue. polydipsia and peripheral edema Although not reported with Navane, evidence indicates there is a relationship between phenothiazine therapy and the occurrence of a systemic lupus erythematosus-like syndrome NOTE Sudden deaths have occasionally been reported in patients who have received certain phenothiazine derivatives. In some cases the cause of death was apparently cardiac arrest or asphyxia due to failure of the cough reflex In others, the cause could not be determined nor could it be established that death was due to phenothiazine administration Dosageand AdmInIstration: Dosage of Navane should be individually adjusted depending on the chronicity and severity of the condition In general. small doses should be used initially and gradually increased to the optimal effective level, based on patient response Some patients have been successfully maintained on once-a-day Navane therapy Usage in children under 12 years of age is not recommended because safe conditions for its use have not been established. Navane Intramuscular Solution Navane For Injection Where more rapid control and treatment of acute behavior is desirable, the intramuscular form of Navane may be indicated It is also of benefit where the very nature of the patient's symptomatology, whether acute or chronic, renders oral administration impractical or even impossible For treatment of acute symptomatology or in patients unable or unwilling to take oral medication, the usual dose is 4 mg of Navane Intramuscular administered 2 to 4 times daily. Dosage may be increased or decreased depending on response Most patients are controlled on a total daily dosage of 16 to mg The maximum recommended dosage is 30 mgiday An oral form should supplant the injectable form as soon as possible It may be necessary to adjust the dosage when changing from the intramuscular to oral dosage forms. Dosage recommendations for Navane ; thiothixene ; Capsules and Concentrate appear in the following parsgraphs Navane Capsules Navane ConcentrateIn milder conditions, an initial dose of 2 mg three times daily If indicated. a subsequent increase to 15 mgday total daily dose is often effective In more severe conditions, an initial dose of 5 mg twice daily The usual optimal dose is 20 to mg daily If indicated, an increase to 60 mg day total daily dose is often effective Exceeding a total daily dose of 60 mg rarely increases the beneficial response. Overdosage: Manifestations include muscular twitching. drowsiness, and dizziness Symptoms of gross overdosage may include CNS depression, rigidity. weakness, torticollis, tremor, salivation, dysphagia, hypotension. disturbances of gait. or coma Treatment Essentially is symptomatic and supportive For Navane oral, early gastric lavage is helpful For Navane oral and Intramuscular, keep patient under careful observation and maintain an open airway. since involvement of the extrapyramidal system may produce dysphagia and respiratory difficulty in severe overdosage If hypotension occurs, the standard measures for managing circulatory shock should be used 1 V fluids and.'or vasoconstrictors. ; If a vasoconstrictor is needed, levarterenol and phenylephrine are the most suitable drugs. Other pressor agents. including epinephrine, are not recommended, since phenothiazine derivatives may reverse the usual pressor action of these agents and cause further lowering of the blood pressure If CNS depression is present and specific therapy is indicated. recommended stimulants include amphetamine. dextroamphetamine, or caffeine and sodium benzoate. Stimulants that may cause convulsions e g picrotoxin or pentylenetetrazol ; should be'avoided Extrapyr# midal symptoms may be treated with antiparkinson drugs There are no data on the use of peritoneal or hemodialysis. but they are known to be of little value in phenothiazine intoxication How Supplied: Navane ; thiothixene is available as capsules containing 1 mg, 2 mg. 5 mg, and 10 mg ofthiothixene in bottles of 100, 1 .000. and unit-dose pack of 100 ; 10 x 10's ; Navane is also available as capsules containing 20 mg ofthiothixene in bottles of 100, 500. and unit-dose pack of tOO ; t0x tO's ; Navane ; thmothixene hydrochloride ; Concentrate is available in 120 ml ; 4 oz ; bottles with an accompanying dropper calibrated at 2 mg, 3 mg. 4 mg. 5 mg. 6 mg. 8 mg, and 10 mg, and in 30 ml bottles with an accompanying dropper calibrated at 2 mg. 3 mg. 4 mg. and 5 mg Each ml contains thiothixene hydrochloride equivalent to 5 mg of thiothixene Contains alcohol, U.S P 7 0% v small loss unavoidable ; Navane ; thiothixene hydrochloride ; Intramuscular solution is available in a 2 amber glass vial in packages of 10 vials Each ml contains thiothixene hydrochloride equivalent to 2 mg of thiothixene. dextrose 5% w v. benzyl alcohol 0.9% w v and propyl gallate 0.02% w v Navane thiothixene hydrochloride ; Intramuscular For Injection is available in amber glass vials in packages of 10 vials When reconstituted with 2 ml Sterile Water for Injection, each ml contains thiothixene hydrochloride equivalent to 5 mg of thiothixene, and 59 6 mg of mannitol The reconstituted solution of Navane Intramuscular For Intection may be stored for 48 hours at room temperature before discarding.
Sudafed pe phenylephrine drugs
Frsistent Tardive Dyskinesia: As with all antipsychotic agents tardive dyskinesia may appear in some patients on long term therapy or may occur after drug therapy has been discontinued. The risk seems to be greater in elderly patients on high-dose therapy, especially females The symptoms are persistent and in some patients appear to be irreversible The syndrome is characterized by rhythmical inveluntary movements ofthe tongue, face, mouth or law e g protrusion of tongue, puffing of cheeks, puckering of mouth, chewing movements ; Sometimes these may be accompanied by involuntary movements of extremities There is no known effective treatmentfor tardive dyskinesia; antiparkinsonism agents usually do not alleviate the symptoms ofthis syndrome It is suggested that all antipsychotic agents be discontinued if these symptoms appear. Should it be necessary to reinstitute treatment, or increase the dosage ofthe agent, or switch to a different antipsychotic agent, the syndrome may be masked. It has been reportedthatfine vermicular movements ofthetongue may be an early sign of the syndrome and ifthe medication is stopped at that time, the syndrome may not develop. Hepatic effects. Elevations of serum transaminase and alkaline phosphatase, usually Iransient, have been infrequently observed in some patients No clinically confirmed cases of jaundice attributable to Navane have been reported Hematologic effects. As is true with certain other psychotropic drugs, leukopenia and leukocytosis, which are usually transient, can occur occasionally with Navane Other antipsychotic drugs have been associated with agranulocytosis, eosinophilia, hemolytic anemia, thrombocytopenia and pancytopenia Allergic reactions: Rash, pruritus, urticaria, photosensitivity and rare cases of anaphylaxis have been reported with Navane. Undue exposure to sunlight should be aveided Although not experienced with Navane, exfoliative dermatitis and contact dermatitis in nursing personnel ; have been reported with certain phenothiazines Endocrine disorders: Lactation, moderate breast enlargement and amenorrhea have occurred in a small percentage olfemales receiving Navane. If persistent, this may necessitate a reduction in dosage or the discontinuation of therapy Phenothiazines have been associated with false positive pregnancy tests, gynecomastia, hypoglycemia, hyperglycemia, and glycosuria Autonomic effects: Dry mouth, blurred vision, nasal congestion, constipation, increased sweating, increased salivation, and impotence have occurred infrequently with Navane therapy. Phenothiazines have been associated with miosis, mydriasis, and adynamic ileus Other adverse reactions. Hyperpyrexia, anorexia, nausea, vomiting, diarrhea, increase in appetite and weight, weakness or fatigue. polydipsia and peripheral edema. Although not reported with Navane, evidence indicates there is a relationship between phenothiazine therapy and the occurrence of a systemic lupus erythematosus-like syndrome NOTE: Sudden deaths have occasionally been reported in patients who have received certain phenothiazine derivatives. In some cases the cause of death was apparently cardiac arrest or asphyxia due to failure of the cough reflex. In others, the cause could not be determined nor could it be established that death was due to phenothiazine administration Dosageand AdmInistratIon: Dosage of Navane should be individually adjusted depending on the chronicity and severity otthe condition In general. small doses should be used initially and gradually increased to the optimal effective level, based on patient response. Some patients have been successfully maintained on once-a-day Navane therapy Usage in children under 12 years of age is not recommended because safe conditions for its use have not been established. Navane Intramuscular Solution: Navane For Injection Where more rapid control and treatment of acute behavior is desirable, the intramuscular form of Navane may be indicated It is also of benefit where the very nature ofthe patient's symptomatology, whether acute or chronic, renders oral administration impractical or even impossible For treatment of acute symptomatology or in patients unable or unwilling to take oral medication, the usual dose is 4 mg of Navane Intramuscular administered 2 to 4 times daily Dosage may be increased or decreased depending on response Most patients are controlled on a total daily dosage of 16 to mg The maximum recommended dosage is 30 mg day. An oralform should supplantthe inlectable form as soon as possible It may be necessaryto adjust the dosage when changing from the intramuscular to oral dosage forms. Dosage recommendations for Navane thiothixene ; Capsules and Concentrate appear in the following paragraphs. Navane Capsules: Navane Concentrate In milder conditions, an initial dose of 2 mg three times daily. If indicated, a subsequent increase to 15 mg day total daily dose is often effective In more severe conditionr, an initial dose of 5 mg twice daily The usual optimal dose is 20 to mg daily If indicated, an increase to 60 mg day total daily dose is often effective Exceeding a total daily dose of 60 mg rarely increases the beneficial response. Overdosags: Manifestations include muscular twitching. drowsiness, and dizziness Symptoms of gross overdosage may include CNS depression, rigidity. weakness, torticollis, tremor, salivation, dysphagia, hypotension, disturbances of gait. or coma Treatment: Essentially is symptomatic and supportive For Navane oral, early gastric lavage is helpful. For Navane oral and Intramuscular, keep patient under careful observation and maintain an open airway, since involvement of the extrapyramidal system may produce dysphagia and respiratory difficulty in severe overdosage. If hypotension occurs, the standard measures for managing circulatory shock should be used l.V fluids and or vasoconstrictors ; If a vasoconstrictor is needed, levarterenol and phenylephrine are the most suitable drugs Other pressor agents. including epinephrine, are not recommended, since phenothiazine derivatives may reverse the usual pressor action of these agents and cause further lowering of the blood pressure. If CNS depression is present and specific therapy is indicated, recommended stimulants include amphetamine, dextroamphetamine, or caffeine and sodium benzoate Stimulants that may cause convulsions e g picrotoxin or pentylenetetrazol ; should beaveided Estrapyramidal symptoms may be treated with antiparkinson drugs There are no data on the use of peritoneal or hemodialysis. but they are known to be of little value in phenothiazine intoxication How Supplied: Navane thiothixene ; is available as capsules containing 1 mg, 2 mg, 5 mg, and 10 mg ofthiothixene in bottles of 100. 1, 000, and unit-dose pack of 100 10 x 10's ; . Navane is also available as capsules containing 20 mg ofthiothixene in bottles of 100, 500. and unit-dose pack of 100 lOx 10's ; Navane thiothixene hydrochloride ; Concentrate is available in 120 mP 4 oz ; bottles with an accompanying dropper calibrated at 2 mg, 3 mg. 4 mg. 5 mg, 6 mg, 8 mg, and 10 mg, and in 30 ml oz. ; bottles with an accompanying dropper calibrated at 2 mg, 3 mg, 4 mg. and 5 mg Each ml contains thiothixene hydrochloride equivalent to 5 mg ofthiothixene. Contains alcohol, U.S P 7.0% v.v smallloss unaveidable ; Navane thiothixene hydrochloride ; Intramuscular solution is available in a 2 amber glass vial in packages of 10 vials. Each ml contains thiothixene hydrochloride equivalent to 2 mg of thiothixene, dextrose 5% w!v, benzyl alcohol 0 9% w.v and propyl gallate 0 02% w v. Navane thiothixene hydrochloride ; Intramuscular For Inlection is available in amber glass vials in packages of 10 vials When reconstituted wilh 2.2 ml of SterileWater for Injection. each ml contains thiothixene hydrochloride equivalent to 5 mg of thiothixene, and 59 6 mg of mannitol. The reconstituted solution of Navane Intramuscular For Injection may be stored for 48 hours at room temperature before discarding.
Is phenylephrine effective
Table 2 Nursing levels at different times in the two hospitals Day Hvidore University Hospital Weekday 2 Nurses 3 Assistants Weekend holiday 1 N, 3 A Great Western Hospital Weekday 1.5 N 2.7 A Weekend holiday 1.2 N 2.7 A Evening Night.
Wendy W Batenburg, Joep H van Esch, Ingrid M Garrelds, Erasmus MC, Rotterdam, Netherlands; Ulrich Jorde, Columbia presbytarian Medical Center, New York, NY; Jorge P van Kats, Pramod R Saxena, Alexander H Danser, Erasmus MC, Rotterdam, Netherlands Patients with chronic heart failure CHF ; treated with the nonselective -adrenergic receptor antagonist carvedilol display a diminished vasopressor response to angiotensin Ang ; II as compared to patients treated with the selective 1-adrenergic receptor antagonist metoprolol. Here we investigated whether this is due to the 1-adrenergic blocking or other ancillary properties of carvedilol. Human coronary microarteries HCMAs; diameter 260 500 m ; , obtained from 18 heart valve donors 6 M, 12 F; age 13 61 years ; who died of non-cardiac causes, were mounted in Mulvany myographs. Concentration-response curves CRCs ; to Ang II, endothelin-1 ET-1 ; and the 1-adrenoceptor agonist phenylephrine were constructed in the presence of the cyclo-oxygenase inhibitor indomethacin 5 M ; . Ang II, ET-1 and phenylephrine constricted HCMAs in a concentration-dependent manner pEC50 8.5 0.1, 8.2 and 4.6 0.2; maximum effect Emax ; 55 17, 121 and 46 17% of the contraction to 100 mM K ; . Carvedilol 10 M ; , metoprolol 10 M ; , the nonselective -adrenergic receptor antagonist propranolol 10 M ; , nor the M ; 1-adrenoceptor antagonist prazosin 10 affected the Ang II CRC. This suggests that 1- and -adrenoceptors are not involved in the direct constrictor effects of Ang II, and that the anti-oxidant and anti-ET-1 properties of carvedilol do not result in Ang II antagonism. When Ang II or ET-1 was added to the organ bath at a concentration that caused a contraction corresponding with 10% of their Emax, Ang II pEC50 4.5 0.1, Emax 113 28; P 0.01 ; , but not ET-1 pEC50 4.6 0.3, Emax 64 17% ; , greatly amplified the response to phenylephrine. Carvedilol fully abolished this Ang II-induced potentiation. Moreover, the AT1 receptor antagonist irbesartan concentration-dependently inhibited the phenylephrine-induced vasoconstriction in the presence of Ang II. In conclusion, AT1- 1-receptor crosstalk greatly sensitizes HCMAs to 1-adrenoceptor agonists. In view of the increased sympathetic tone in CHF, the 1-adrenoceptor blocking effects of carvedilol most likely underly its capacity to antagonize Ang II in this setting. Crosstalk may also explain why AT1 receptor antagonism blocks phenylephrine-induced vasoconstriction and phenylpropanolamine.
HCF claimed at the hearing last month that if Ms Strong won it would have a "dramatic effect" on the industry and that it would have "a very significant impact" on the fund because similar compensation would have to be paid to all other singleparent member, as well as on the industry in general. It hinted that it would have to raise premiums if forced to pay such compensation. In 1996, the federal government required health funds to expand their two categories of family and single health cover to also include singleparent and couple options, and allowed.
Phenylephrine priapism treatment
Posted by: september 29, 2006 there was an article in the post sometime this week that says the effective dose of phenylephrine is 24 mg in tests, not the 10 mg being marketed and photofrin.
Topical decongestant sprays containing phenylephrine e, g.
The oral cavity is viewed as a convenient and easily accessible site for the delivery of therapeutic agents 1 ; . Within the oral cavity, drugs can be administered from the buccal gingiva or the sublingual space either for the treatment of local conditions eg, thrush ; or for the systemic treatment of diseases eg, angina ; . The advances in bioadhesive and controlled release technology have stimulated a renewal of interest in the delivery of drugs to, or via, the buccal route 2 ; . Buccal bioadhesive drug BBD ; devices can now be designed to remain in contact with the oral mucosa while providing controlled release characteristics over a prolonged period of time. A combination of these two attributes can be achieved by the use of suitable bioadhesive materials 3-6 ; . Appropriate materials for the bioadhesive drug delivery consist mainly of hydrogel-forming polymers 7, 8 ; . They have been called "wet" adhesives because they require moisture to exhibit the adhesive property 9 ; . This may be supplied by the saliva, which may also act as the dissolution medium. The various polymers considered suitable for the development of bioadhesive devices are cellulosic derivatives methylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose natural gums guar gum, karaya gum, xanthan gum, locust bean gum, veegum sodium alginate; polyoxyethylenes; and polyacrylates carbopol and polycarbophil ; 10-12 ; . Polyacrylic acid polymers have received considerable attention in the development of bioadhesive drug delivery systems 5-9 ; . The high concentration of carboxyl groups in a dry tablet of polyacrylic acid generates a low surface pH between 2 and 3 ; on moistening 13 ; . A low pH would be expected to damage the contacting mucosal surface, and this has been reported in an in vivo study involving human volunteers 14 ; . Results of preliminary investigation in human volunteers on the and pilocarpine.
Acetaminophen dextromethorphan phenylephrine hcl
On day 15, mean arterial pressure, heart rate, central venous pressure, and renal sympathetic nerve activity were recorded in conscious rats at rest and in response to air-jet stress, intracerebroventricular injection of the alpha 2-agonist guanabenz 25 and 75 g ; or angiotensin ii 30 ng ; , acute volume expansion, and ramp changes of blood pressure by + - 50 with phenylephrine and nitroprusside.
In rectal cancer was generally reported following rectal cancer excision, a measurement in mm ; was seldom reported. The resection margin at the ends of the bowel has generally also been considered to be important. Interestingly, only 2 of 20 patients in our study with rectal or sigmoid cancer and a distal resection margin of less than 2.0 cm developed local recurrence i.e. not different from those with a greater margin ; . Similarly, 3 of 7 patients with rectal cancer and a positive circumferential radial margin ; developed recurrence. In this connection, a recent large review of CRC resections between 1971 and 2001 from Concord Hospital in Sydney, Australia reported that while 5.9% of patients had a positive resection margin, this did not necessarily herald local recurrence and poor survival.28 However, they did find those who had high-grade tumours or apical node involvement plus a positive margin fared significantly worse. Other factors like preoperative staging and preoperative chemo radiotherapy, as well as surgical specialisation and adopting standard surgical techniques were noted to make a difference in the incidence of local recurrence.28 and pima.
Phenylephrine and guaifenesin
ASSESSING BEHAVIOR IN MS: THE FRONTAL SYSTEMS BEHAVIOR SCALE FrSBe ; Nancy D. Chiaravalloti and John DeLuca, Kessler Medical Rehabilitation Research and Education.
| Phenylephrine hcl tablets dosage18. Dekker AW, Nieuwenhuis HK, Verdonck LF. Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemia. Cancer 1990; 65: 18914. Mehta J, Powles R, Singhal S, Horton C, Hamblin M, Zomas A, et al. Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia. Semin Hematol 1996; 33: 1823. Kimby E, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in acute myeloid leukaemia. Acta Oncol 2001; 40: 23152. Raanani P, Shpilberg O, Gillis S, Avigdor A, Hardan I, Berkowicz M, et al. Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine. Leuk Res 1999; 23: 695700. Schiller G. Treatment of resistant acute myeloid leukemia. Blood Rev 1991; 5: 2206. Kern W, Schleyer E, Unterhalt M, Wormann B, Buchner T, Hiddemann W. High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study. Cancer 1997; 79: 5968. Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR, Glick JH. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia. J Clin Oncol 1984; 2: 5459 and pindolol.
Tion B when a Player accepts salary arbitration pursuant to this paragraph 3 ; . If the Player does not accept the former Club's offer to proceed to salary arbitration as provided above, the former Club, after the succeeding January 8, shall not be entitled and shall lose all rights to negotiate with or sign the Player, until the succeeding May 1. 4 ; Compensation a ; The former Club of a Player who: i ; became a free agent under this Section B; and ii ; ranks as a Type A, B or C Player as defined below, shall be entitled to receive compensation subject to the provisions of subparagraph c ; below. Such compensation shall consist solely of the amateur draft choices described in subparagraph c ; below and shall be awarded in the Major League Rule 4 Draft succeeding the Player's election of free agency. b ; A Type A, B or C Player shall be a Player who became a free agent under this Section and who ranks as a Type A, B or C Player under the statistical system of ranking Players set forth in the document entitled "A Statistical System for the Ranking of Players, " using statistics based on a two-year average for each respective position group. Type A Players: A Type A Player shall be a Player who ranks in the upper thirty percent 30% ; of his respective position group. Type B Players: A Type B Player shall be a Player who ranks in the upper fifty percent 50% ; but not in the upper thirty percent 30% ; of his respective position group. Type C Players: A Type C Player shall be a Player who ranks in the upper sixty percent 60% ; but not in the upper fifty percent 50% ; of his respective position group. c ; A Type A, B or C Player shall be subject to compensation only if i ; he offered salary arbitration by his former Club on or before December 7 pursuant to Section B 3 ; of this Article XX and signs a contract with another Club; or ii ; he signs a contract with another Club prior to December 7. Further, a Type C Player shall not be subject to compensation if he iii ; has not signed a Uniform Player's Contract or reached agreement on terms as of the March 1 suc68.
Acetaminophen and phenylephrine during pregnancy
Results. Altered central neural modulation of baroreceptor afferent information provides an alternative explanation. Clonidine decreases sympathetic outflow and enhances baroreceptor-interbeat interval sensitivity, 25 26 and hypernoradrenergic hypertensive subjects show larger decreases in mean arterial pressure after clonidine than do normonoradrenergic hypertensive subCIRCULATION and pitocin.
|
Like activities, on aqueous humor dynamics and fundus circulation. Invest Ophthalmol Vis Sci. 1998; 39: 736 Ishii K, Araie M. A monkey chair specially designed for ophthalmic examinations and intraocular pressure measurement in the conscious cynomolgus monkey [in Japanese]. Nippon Ganka Gakkai Zasshi. 1996; 100: 507512. Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol. 1996; 40: 339 Tomita K, Araie M, Tamaki Y, Nagahara M, Sugiyama T. Effects of nilvadipine, a calcium antagonist, on rabbit and optic nerve head circulation in NTG subjects. Invest Ophthalmol Vis Sci. 1999; 40: 1144 Kozuma C, Macklin W, Cumminus LM, Mauer R. Anatomy, physiology, and biochemistry of the rabbit. In: Weisbroth SH, Flatt RE, Kraus AL, eds. The Biology of the Laboratory Rabbit. New York: Academic Press; 1998; 50 72. Alm A. Ocular circulation. In: Hart WM, ed. Adler's Physiology of the Eye. Clinical Application. St. Louis: Mosby-Year Book; 1992: 183227. Koelle JS, Riva CE, Petring BL, Cranstoun SD. Depth of tissue sampling in the optic nerve head using laser Doppler flowmetry. Lasers Med Sci. 1993; 8: 49 Benowitz NL, Jacob P III, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 1982; 221: 368 Leb G, Derntl F, Robin E, Bing RJ. The effect of nicotine on effective and total coronary blood flow in the anesthetized closedchest dog. J Pharmacol Exp Ther. 1970; 173: 138 Attinger EO. The cardiovascular system. In: Attinger EO, ed. Pulsatile Blood Flow. New York: McGraw-Hill; 1964: 114. Stjernschantz J, Selen G, Sjoquist B, Resul B. Preclinical pharma cology of latanoprost, a phenyl-substituted PGF2 analogue. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23: 513518. Dinslage S, McLaren J, Brubaker R. Intraocular pressure in rabbits by telemetry II: effects of animal handling and drugs. Invest Ophthalmol Vis Sci. 1998; 39: 24852489. Lee PY, Podos SM, Severin C. Effect of prostaglandin F2 on aqueous humor dynamics of rabbit, cat and monkey. Invest Ophthalmol Vis Sci. 1984; 9: 10871093. Gonnerring RS, Dortzbach RK, Erickson KA, Kaufman PL. The cynomolgus monkey as a model for orbital research. I: normal anatomy. Curr Eye Res. 1984; 3: 529 Michelson G, Schmauss B. Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol. 1995; 79: 1126 Isono H, Kimura Y, Aoyagi K. Analysis of choroidal blood flow by laser speckle flowgraphy [in Japanese]. Nippon Ganka Gakkai Zasshi. 1997; 101: 684 Sugiyama K, Bacon DR, Cioffi GA, Fahrenback WH, Van Buskirk EM. The effects of phenylephrine on the ciliary body and optic nerve head microvasculature in rabbits. J Glaucoma. 1992; 1: 156 and phenylephrine.
Phenylephrine drug action
Phenylephrine hydrochloride
Japanese encephalitis symptoms, breech ring, fibroadenoma characteristics, duodenum bypass and hyperosmolar metabolic acidosis. Premature baby 8 weeks, kinetics phoenix az, monoclonal antibody humanization and false negative error or dendritic cell powerpoint.
Guaifenesin phenylephrine hc
Phenhlephrine, phenyleephrine, phenylepjrine, 0henylephrine, pbenylephrine, phenylephrne, phenylephrune, phenylephhrine, phenulephrine, phenylephrinf, phwnylephrine, phenylephribe, phebylephrine, phenylpehrine, phenylephrinr, phenyleprhine, phenylephdine, phenylfphrine, pjenylephrine, phenlyephrine.
Phenylephrine hcl dosage information
Sudafed pe phenylephrine drugs, is phenylephrine effective, phenylephrine priapism treatment, acetaminophen dextromethorphan phenylephrine hcl and phenylephrine and guaifenesin. Phenylephrine hcl tablets dosage, acetaminophen and phenylephrine during pregnancy, phenylephrine drug action and phenylephrine hydrochloride or guaifenesin phenylephrine hc.
|
